Submitted by dcc on Thu, 2024-08-01 15:26 Study Title: Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low Tumor Burden Follicular LymphomaCIRB: Adult CIRB - Late Phase EmphasisLead Group: SWOGStatus: ActiveReview Status: Available to Open
